FDA Inspection 1305512 — Give Legacy, Inc.

Give Legacy, Inc. — FEI 3015988970

The FDA completed an inspection of Give Legacy, Inc. on Feb 27, 2026 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 27, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.